These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 346130)

  • 1. Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].
    Boughton-Smith NK; Vane JR; Whittle BJ
    Br J Pharmacol; 1978 Mar; 62(3):413P. PubMed ID: 346130
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of prostacyclin, a stable analogue, 6 beta-PGI1 and 6-oxo-PGF1 alpha on canine isolated parietal cells [proceedings].
    Soll AH; Whittle BJ
    Br J Pharmacol; 1979 May; 66(1):97P-98P. PubMed ID: 378311
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    Prostaglandins; 1978 Jun; 15(6):955-67. PubMed ID: 358297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
    Kauffman GL; Whittle BJ; Aures D; Grossman MI
    Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
    Kauffman GL; Whittle BJ; Aures D; Vane JR; Grossman MI
    Gastroenterology; 1979 Dec; 77(6):1301-6. PubMed ID: 387511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin analogues inhibit canine parietal cell activity and cyclic AMP formation.
    Soll AH; Whittle BJ
    Prostaglandins; 1981 Feb; 21(2):353-65. PubMed ID: 6261301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship (SAR) among prostacyclin (PGI2) analogues.
    Kovács G; Székely I; Stadler I; Körmöczy P
    Acta Physiol Hung; 1984; 64(3-4):225-30. PubMed ID: 6397963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 9. Interrelationships between the chemical structure of prostanoids and prostacyclins and their cytoprotective effects on the ethanol-induced gastric mucosal damage in rats (a comparative experimental study).
    Székely I; Jávor T; Kovács G; Botár S; Morón F; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):231-5. PubMed ID: 6397964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological activity of PGI2 and its metabolite 6-oxo-PGF1alpha on human uterus and fallopian tubes.
    Omini C; Pasargiklian R; Folco GC; Fano M; Berti F
    Prostaglandins; 1978 Jun; 15(6):1045-54. PubMed ID: 358294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of prostacyclin and 6-keto-PGFl alpha on coronary vascular resistance].
    Boroian RG
    Zh Eksp Klin Med; 1978; 18(4):40-4. PubMed ID: 360725
    [No Abstract]   [Full Text] [Related]  

  • 13. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the cytoprotective effect of prostacyclin on gastric epithelial cells of rats by colchicine.
    Karácsony G; Bálint GA; Lukács G; Varró V
    Acta Physiol Acad Sci Hung; 1982; 60(3):143-8. PubMed ID: 6764328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of PGI2, 7-oxo-PGI2 and 17-aza-PGF2 alpha derivate on the development of indomethacin-induced intestinal mucosal damage in rats.
    Garamszegi M; Beró T; Jávor T; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):349-53. PubMed ID: 6397968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of prostacyclin and its product 6-oxo-PGF1alpha by the gastric mucosa of several species [proceedings].
    Moncada S; Salmon JA; Vane JR; Whittle BJ
    J Physiol; 1978 Feb; 275():4P-5P. PubMed ID: 344857
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits.
    Armstrong JM; Lattimer N; Moncada S; Vane JR
    Br J Pharmacol; 1978 Jan; 62(1):125-30. PubMed ID: 339981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of gastric acid secretion and gastric erosions by prostacyclin and other prostaglandins.
    Whittle BJ
    Pol J Pharmacol Pharm; 1978; 30(2-3):167-70. PubMed ID: 353764
    [No Abstract]   [Full Text] [Related]  

  • 20. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
    Whittle BJ; Moncada S; Vane JR
    Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.